EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Role of PPAR α and Its Agonist in Renal Diseases

Ching-Feng Cheng, Hsi-Hsien Chen, Heng Lin

PPAR Research · 2010 · 2010 · 1-6

DOI: 10.1155/2010/345098 ↗
AbstractBibliografische Angaben

Abstract

Peroxisome proliferator-activated receptor (PPAR)- α , a member of a large nuclear receptor superfamily, plays a major role in the regulation of lipid metabolism. Recently, PPAR α activation has been shown to confer additional benefits on endothelial function, kidney function, and anti-inflammation, suggesting that PPAR α agonists may be good candidates for treating acute renal failure. In clinical application, PPAR- α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. This paper focuses on signaling pathways, ligand selectivity, and physio-pathological roles of PPAR α in kidney diseases and the therapeutic utility of PPAR α modulators in the treatment of diabetes and inflammation-induced nephropathy. Implication of new and more potent PPAR- α activators could provide important insights into the overall benefits of activating PPAR- α clinically for the treatment of dyslipidemia and the prevention of diabetic or inflammation-induced nephropathy in the future.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →